Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial-Reference-Cited by-同舟云学术

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

Published:2017-10 Issue:10105 Volume:390 Page:1843-1852
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kandzari David E,Mauri Laura,Koolen Jacques J,Massaro Joseph M,Doros Gheorghe,Garcia-Garcia Hector M,Bennett Johan,Roguin Ariel,Gharib Elie G,Cutlip Donald E,Waksman Ron

Publisher

Elsevier BV

Subject

General Medicine

Reference44 articles.

1. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study;Daemen;Lancet,2007

2. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry;Kimura;Circulation,2012

3. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor drug-eluting stents;Byrne;J Am Coll Cardiol,2010

4. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions. The SPIRIT II trial;Claessen;Circ Cardiovasc Intervent,2009

5. Late restenosis following sirolimus-eluting stent implantation;Kuriyama;J Am Coll Cardiol Intv,2011

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies;Life Sciences;2024-09

2. Clinical outcomes with biodegradable versus durable polymer drug-eluting stents in patients with ST-elevation myocardial infarction;Cardiovascular Revascularization Medicine;2024-08

3. Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up;European Journal of Medical Research;2024-07-27

4. Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial;Circulation: Cardiovascular Interventions;2024-07

5. Real‐World Clinical Performance of a Novolimus‐Eluting Stent Versus a Sirolimus‐Eluting Stent;Clinical Cardiology;2024-07